Rudolf Tomek
- Chemical Health and Safety top 5%
- Occupational Therapy top 5%
-
- Carcinogens and Genotoxicity Assessment 1
-
- HER2/EGFR in Cancer Research 3
- Cancer Treatment and Pharmacology 2
- Lung Cancer Research Studies 2
- CAR-T cell therapy research 1
-
- Radiopharmaceutical Chemistry and Applications 3
-
- Lung Cancer Treatments and Mutations 2
- Renal cell carcinoma treatment 1
Rudolf Tomek
8 papers receiving 55 citations
Peers
Comparison fields: 5 of 33
- Chemical Health and Safety 18
- Occupational Therapy 32
- Cancer Research 30
- Microbiology 6
- Oncology 13
Countries citing papers authored by Rudolf Tomek
This map shows the geographic impact of Rudolf Tomek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rudolf Tomek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rudolf Tomek more than expected).
Fields of papers citing papers by Rudolf Tomek
This network shows the impact of papers produced by Rudolf Tomek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rudolf Tomek. The network helps show where Rudolf Tomek may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rudolf Tomek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Abstract 16961: Influence of Angiotensin Conversion Enzyme Gene Polymorphism on Cardiotoxicity Caused by Immunotherapy with Trastuzumab | 2012 | 0 |
| 2 | [Clinical recommendations for treating and monitoring patients with renal cancer]. | 2012 | 1 |
| 3 | Influence of Angiotensin Conversion Enzyme Gene Polymorphism on Cardiotoxicity Caused by Immunotherapy with Trastuzumab | 2012 | 1 |
| 4 | [Clinical recommendations for diagnosis, treatment and monitoring of patients with invasive breast cancer]. | 2012 | 2 |
| 5 | Radiotherapy of stage IEA primary breast lymphoma: case report. | 2002 | 1 |
| 6 | 1998 | 47 | |
| 7 | 1990 | 3 | |
| 8 | 1988 | 1 | |
| 9 | 1987 | 2 | |
| 10 | 1985 | 1 |
About Rudolf Tomek
Rudolf Tomek is a scholar working on Occupational Therapy, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 10 papers that have together received 59 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (3 papers), HER2/EGFR in Cancer Research (3 papers), Cancer Treatment and Pharmacology (2 papers), Lung Cancer Research Studies (2 papers), Lung Cancer Treatments and Mutations (2 papers), Renal cell carcinoma treatment (1 paper), Carcinogens and Genotoxicity Assessment (1 paper) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Chemical Health and Safety (18 citations), Occupational Therapy (32 citations) and Cancer Research (30 citations). Rudolf Tomek has collaborated with scholars based in Croatia, Russia and Czechia. Frequent co-authors include Anamarija Jazbec, August Mijić, Krsto Kolarić, Nada Vrkić, Kiterie M. E. Faller, Zdeněk Mechl, Mario Štefanović, Željko Vojnović, Mirna Šitum and M. Živković. Their work appears in journals such as Circulation, Lung Cancer and Mutation Research/Genetic Toxicology and Environmental Mutagenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.